Blueprint Medicines Corp Uncategorized Contracts & Agreements

9 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment Agreement dated as of December 23, 2022 by and between the Registrant and Jeffrey W. Albers
Blueprint Medicines Corp
Biotechnology
2022
Blueprint Medicines Corporation Amended and Restated 2020 Inducement Plan
Blueprint Medicines Corp
Biotechnology
DE
2022
Description of the Registrants securities registered pursuant to Section 12 of the Securities and Exchange Act of 1934, as amended
Blueprint Medicines Corp
Biotechnology
2020
[***] INDICATES MATERIAL THAT HAS BEEN OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED. ALL SUCH OMITTED MATERIAL HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE...
Blueprint Medicines Corp
Biotechnology
2017
[***] INDICATES MATERIAL THAT HAS BEEN OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED. ALL SUCH OMITTED MATERIAL HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE...
Blueprint Medicines Corp
Biotechnology
2017
*** Text Omitted and Filed Separately with the Securities and Exchange Commission Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4) and 230.406
Blueprint Medicines Corp
Biotechnology
DE
2016
***Text Omitted and Filed Separately with the Securities and Exchange Commission Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4) and 230.406
Blueprint Medicines Corp
Biotechnology
2016
***Text Omitted and Filed Separately with the Securities and Exchange Commission Confidential Treatment Requested Under 17 C.F.R. Sections 200.80(b)(4) and 230.406
Blueprint Medicines Corp
Biotechnology
MA
2015
BLUEPRINT MEDICINES CORPORATION SECOND AMENDED AND RESTATED STOCKHOLDERS AGREEMENT
Blueprint Medicines Corp
Biotechnology
MA
2015